These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 28292549)

  • 1. Re: Kenneth A. Iczkowski's Letter to the Editor re: Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5.
    Montironi R; Lopez-Beltran A; Cheng L; Gasparrini S; Montironi MA; Massari F; Scarpelli M; Montorsi F
    Eur Urol; 2017 Aug; 72(2):e37-e38. PubMed ID: 28292549
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5.
    Iczkowski KA
    Eur Urol; 2017 Aug; 72(2):e36. PubMed ID: 28284740
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides.
    Montironi R; Gasparrini S; Mazzucchelli R; Massari F; Cheng L; Lopez-Beltran A; Montorsi F; Scarpelli M
    Eur Urol; 2017 Feb; 71(2):e73-e75. PubMed ID: 27568062
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Pim J. van Leeuwen and Henk G. van der Poel's Letter to the Editor re: Karim A. Touijer, Robert J. Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.
    Touijer K
    Eur Urol; 2018 Jul; 74(1):e18-e19. PubMed ID: 29691082
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Karim A. Touijer, Robert Jeffery Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.
    van Leeuwen PJ; van der Poel HG
    Eur Urol; 2018 Jul; 74(1):e15-e17. PubMed ID: 29661485
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Michael Froehner, Rainer Koch, and Manfred P. Wirth's letter to the editor re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A. Eastham. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol 2014;65:20-5.
    Touijer KA; Mazzola CR; Sjoberg DD; Scardino PT; Eastham JA
    Eur Urol; 2014 Feb; 65(2):e25-6. PubMed ID: 24188723
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Rodolfo Montironi, Silvia Gasparrini, Antonio Lopez-Beltran, et al's Letter to the Editor re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790-807. Benign Müllerian Lesions in the Urinary Bladder: Endometriosis, Endocervicosis, Endosalpingiosis, and Müllerianosis.
    Leone Roberti Maggiore U; Ferrero S; Candiani M; Somigliana E; Viganò P; Vercellini P
    Eur Urol; 2017 Nov; 72(5):e142. PubMed ID: 28583309
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A. Eastham. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol 2014;65:20-5.
    Froehner M; Koch R; Wirth MP
    Eur Urol; 2014 Feb; 65(2):e24. PubMed ID: 24184026
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Alberto Briganti, Michael L. Blute, James H. Eastham, et al. Pelvic lymph node dissection in prostate cancer. Eur urol 2009;55:1251-65.
    Alcover J; Filella X
    Eur Urol; 2009 Dec; 56(6):e53. PubMed ID: 19773114
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al's Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e53.
    Leibowitz-Amit R
    Eur Urol; 2019 Jul; 76(1):e19. PubMed ID: 30928161
    [No Abstract]   [Full Text] [Related]  

  • 11. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer.
    Touijer KA; Eastham JA
    Eur Urol; 2016 Nov; 70(5):738-739. PubMed ID: 26961255
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Karim A. Touijer, Daniel D. Sjoberg, Nicole Benfante, et al. Limited Versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2021.03.006.
    Yang B; Yang G; Yao X
    Eur Urol Oncol; 2021 Oct; 4(5):852-853. PubMed ID: 34535419
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019, 76:871.
    Sighinolfi MC; Rocco B
    Eur Urol; 2020 May; 77(5):e128-e129. PubMed ID: 32067794
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Francesco Montorsi and Giorgio Gandaglia's letter to the editor re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur urol 2014;66:191-9.
    Gakis G; Stief CG
    Eur Urol; 2014 Dec; 66(6):e109-10. PubMed ID: 25204223
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Alessia Cimadamore, Francesco Montorsi, and Antonio Lopez-Beltran's Letter to the Editor re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667-75: How Does Circulating DNA Reach the Blood Stream?
    Wyatt AW; Chi KN; Gleave ME
    Eur Urol; 2019 Sep; 76(3):e73-e74. PubMed ID: 31167749
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9.
    Abdollah F; Montorsi F; Briganti A
    Eur Urol; 2015 Aug; 68(2):e37-8. PubMed ID: 25801052
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Filippo Alongi, Rosario Mazzola, Dario Aiello and Matteo Salgarello's Letter to the Editor re: Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71:37-43. A Step Forward in the Era of Functional Imaging?: Functional Imaging and Micrometastatic Disease: Implications for Radiotherapy Field Design.
    Spratt DE; Zelefsky MJ
    Eur Urol; 2017 Apr; 71(4):e123-e124. PubMed ID: 27836418
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1% K. Touijer, F. Rabbani, J. R. Otero, F. P. Secin, J. A. Eastham, P. T. Scardino And B. Guillonneau J Urol 2007; 178: 120-124.
    Joseph JV; Greene T
    J Urol; 2008 Feb; 179(2):789-90. PubMed ID: 18082824
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sentinel lymph node dissection in prostate cancer. Experience after more than 800 interventions].
    Weckermann D; Hamm M; Dorn R; Wagner T; Wawroschek F; Harzmann R
    Urologe A; 2006 Jun; 45(6):723-7. PubMed ID: 16586052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92. Do the Data Violate Kaplan-Meier Assumptions?
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):e31. PubMed ID: 28214034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.